Five Prime Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Five Prime Therapeutics's estimated annual revenue is currently $75M per year. 0
- Five Prime Therapeutics's total funding is $155M.
Employee Data
- 00
Five Prime Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder, Chairman and CEO | Reveal Email/Phone |
2 | Facility Manager | Reveal Email/Phone |
3 | Executive Chairman | Reveal Email/Phone |
Five Prime Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Five Prime Therapeutics?
FivePrime is a drug discovery and development company primarily focused on therapeutic proteins. The Company is creating a new paradigm in drug discovery by leveraging the Pharmanome(TM) -- the entire set of pharmaceutically relevant genes and proteins. The Company is currently screening its secreted protein set for factors involved in lymphocyte reconstitution, inflammation, and Type II diabetes, with additional programs in cancer, osteoarthritis and regenerative medicine. FivePrime seeks strategic partners interested in discovery and development collaborations for proteins, antibodies and small molecules. Founded in December 2001, Five Prime Therapeutics, Inc. is headquartered in South San Francisco, California. Investors in FivePrime include K.K. Dnaform, Kleiner Perkins Caufield & Byers, TPG Ventures, and Versant Ventures.
keywords:N/A
$155M
Total Funding
N/A
Number of Employees
$75M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Five Prime Therapeutics News
... Market 2022 COVID-19 Impact Analysis and Forecast to 2028 | Top Players as Atox Bio Ltd, Bristol-Myers Squibb Co, Five Prime Therapeutics Inc, Johnson.
Bayer AG, Bayhill Therapeutics, Biogen Idec, Cinnagen, Daiichi Sankyo, Eli Lilly, Fast Forward Llc, Antisense Therapeutics, Apitope, Five Prime Therapeutics...
... Outlook And Forecast | Ablynx NV, Amgen Inc, Apogenix GmbH, Bristol-Myers Squibb Company, Five Prime Therapeutics Inc, Incyte Corp, MedImmune LLC,...
Other Companies in South San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $90.3M | 0 | N/A | $711.5M |
#2 | $11.6M | 0 | N/A | $319.7M |
#3 | $0.2M | 1 | -67% | N/A |
#4 | $0.3M | 2 | 0% | N/A |
#5 | $0.6M | 4 | 0% | N/A |